Treatment of Brain Metastases From Breast Cancer With Eribulin Mesylate
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Eribulin (Primary)
- Indications Brain metastases; Breast cancer
- Focus Therapeutic Use
- 28 Mar 2017 Planned primary completion date changed from 1 Jan 2017 to 15 Sep 2017.
- 25 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 26 Oct 2015 New trial record